Dec 31 (Reuters) - UK's Medicines and Healthcare
products Regulatory Agency (MHRA) said on Tuesday it had
approved Merck's ( MRK ) therapy, sotatercept, to treat a rare
lung condition.
(Reporting by Bhanvi Satija in Bengaluru; Editing by Anil
D'Silva)